Quality control standards for fluoroquinolone APIs specifically intended for animals have been further standardized.

Release time:2026-01-14 17:14

Quality control standards for fluoroquinolone APIs specifically intended for animals are being gradually refined to ensure the safety and efficacy of drug use.


Quality control standards for fluoroquinolone APIs specifically intended for animals are being gradually refined to ensure the safety and efficacy of drug use. In terms of assay methods, high-performance liquid chromatography (HPLC) serves as the core technique. By precisely separating and detecting the active pharmaceutical ingredients, HPLC ensures that the content of the active components in the APIs falls within the specified range, thereby preventing insufficient dosage from compromising therapeutic efficacy or excessive dosage from triggering adverse reactions.

Impurity control is another critical step. Process impurities generated during manufacturing and degradation products that may form during storage must both be removed through stringent process controls, intermediate purification, and refining procedures. At the same time, advanced techniques such as high-performance liquid chromatography and gas chromatography are employed to quantitatively analyze impurity levels, ensuring that impurity concentrations remain below safety thresholds.

Stability studies are equally indispensable. By conducting accelerated and long-term stability tests under simulated storage conditions, we can evaluate the stability of the active pharmaceutical ingredient and provide a scientific basis for establishing appropriate storage conditions and shelf life. In addition, dissolution studies simulate the drug release process in the body, ensuring that the active pharmaceutical ingredient maintains good dissolution performance under various conditions, thereby guaranteeing bioavailability.

In terms of microbial limits, the content of microorganisms such as bacteria and fungi in active pharmaceutical ingredients is rigorously tested to prevent contamination that could lead to drug degradation and ensure medication safety. The standardized implementation of these quality control criteria helps enhance the overall quality level of fluoroquinolone APIs specifically intended for animals.